Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.8
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 6 Months Ended
Jun. 30, 2014
Jun. 30, 2013
Cash flows from operating activities attributable to continuing operations:    
Net income $ 65,122 $ 74,824
Adjustments to reconcile income from continuing operations to net cash provided by operating activities attributable to continuing operations:    
Depreciation and amortization 21,559 19,904
Stock-based compensation expense 7,810 7,254
Amortization of debt issuance costs 552 563
Deferred income taxes (4,115) 3,536
Bad debt expense 9,225 10,018
Excess tax benefits from stock-based awards (4,981) (5,295)
Other 135 1,019
Changes in current assets and liabilities:    
Accounts receivable 55,993 55,719
Inventories (55,377) (24,943)
Prepaid expenses and other assets (14,035) (16,345)
Accounts payable, accrued expenses and other current liabilities (53,690) (92,683)
Net cash provided by operating activities attributable to continuing operations 28,198 33,571
Cash flows from investing activities attributable to continuing operations:    
Capital expenditures (15,901) (22,741)
Other (491) 0
Net cash used in investing activities attributable to continuing operations (16,392) (22,741)
Cash flows from financing activities attributable to continuing operations:    
Repayment of long-term debt (6,250) (3,125)
Repurchase of common stock (50,979) (112,683)
Cash dividends paid (26,429) (19,486)
Proceeds from issuance of common stock 1,441 3,272
Tax withholdings related to stock-based awards (8,653) (11,900)
Excess tax benefits from stock-based awards 4,981 5,295
Payment of contingent consideration obligation 0 (2,172)
Net cash used in financing activities attributable to continuing operations (85,889) (140,799)
Total cash used in continuing operations (74,083) (129,969)
Cash flows from discontinued operations:    
Total cash used in discontinued operations (18) (147)
Net decrease in cash and cash equivalents (74,101) (130,116)
Cash and cash equivalents at beginning of period 196,433 222,092
Cash and cash equivalents at end of period $ 122,332 $ 91,976